First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models
暂无分享,去创建一个
David J Brayden | D. Mash | O. Hardiman | S. O’Mara | K. Tipton | C. Walsh | A. Vajda | M. Elamin | J. Callanan | O. Gobbo | S. Ryan | J. A. Kelly | G. Scalabrino | L. Corte | M. Campbell | C. Stefanini | K. O’boyle | N. Cole | N. Boyle | J. Hunter | G. R. Slator | C. H. Williams | Margaret M. Goggin | M. Colivicchi